Bitte beachten Sie, dass die von Ihnen aufgerufene Seite nicht in Ihrer Standardsprache vorliegt. Sie nutzen unsere Plattform nun in einer anderen Sprache.
This chart shows the breakdown by segment of the turnover of medicines sold in France and abroad in 2017. The sale of reimbursable medicines contributed to about 34 percent of the total turnover, while the export of medicines in France accounted for almost half of the market.
Breakdown of medicine sales in France and abroad in 2017, by segment
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Pharmaceutical industry in China
Key Figures
7
- Premium Statistic Global pharmaceutical market - revenue distribution 2010-2022, by region
- Premium Statistic Total operating revenue of China's pharmaceutical industry 2013-2022
- Premium Statistic Breakdown of pharmaceutical industry revenue in China 2021, by segment
- Premium Statistic Breakdown of profit in the pharmaceutical industry in China 2021, by segment
- Premium Statistic Monthly production volume of chemical API in China 2019-2023
- Premium Statistic Monthly production volume of TCM patent drugs in China 2019-2022
- Premium Statistic Value of investments in the pharmaceutical industry in China 2019-2021
Drug evaluation and approval
8
- Premium Statistic Number of drug approval applications submitted in China 2018-2021
- Premium Statistic Number of approved drug evaluation applications in China 2021, by type of application
- Premium Statistic Number of IND applications of innovative drugs approved in China 2018-2021
- Premium Statistic Number of NDA of innovative drugs approved in China 2018-2021
- Premium Statistic Number of chemical drug applications with technical reviews approved in China 2021
- Premium Statistic Therapeutic areas for approved chemical drug IND applications in China 2021
- Premium Statistic Therapeutic areas for approved chemical drug NDA in China 2021
- Premium Statistic Number of technically reviewed biopharmaceutical applications approved in China 2021
Sales channels
7
- Premium Statistic End market sales volume of pharmaceutical industry in China 2012-2022
- Premium Statistic Drug sales revenue distribution in China 2022, by sales channel
- Premium Statistic Sales revenue of medicaments via public hospitals in China 2011-2022
- Premium Statistic Sales revenue of medicaments via retail pharmacies in China 2011-2022
- Premium Statistic Sales revenue of medicaments via physical retail pharmacies in China 2011-2022
- Premium Statistic Sales revenue of medicaments via online retail pharmacies in China 2011-2022
- Premium Statistic Export value of medicinal and pharmaceutical products from China 2012-2022
Pharmaceutical enterprises
7
- Premium Statistic Leading biotech and pharmaceutical companies on the Fortune China 500 ranking 2023
- Premium Statistic Largest Chinese pharmaceutical companies as of 2023, based on profit
- Premium Statistic Largest Chinese pharmaceutical companies 2023, based on market value
- Premium Statistic Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Premium Statistic Annual revenue of Sinopharm 2010-2022
- Premium Statistic Annual revenue of Jiangsu Hengrui Pharmaceuticals 2015-2022
- Premium Statistic Annual revenue of Sinovac Biotech Ltd. 2016-2022
Further related statistics
10
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
- Merck & Co cash dividends declared 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
Further Content: You might find this interesting as well
Statistics
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
- Merck & Co cash dividends declared 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
LEEM. (July 2, 2018). Breakdown of medicine sales in France and abroad in 2017, by segment [Graph]. In Statista. Retrieved June 11, 2024, from https://www.statista.com/statistics/778674/medicines-turnover-france-and-export/
LEEM. "Breakdown of medicine sales in France and abroad in 2017, by segment." Chart. July 2, 2018. Statista. Accessed June 11, 2024. https://www.statista.com/statistics/778674/medicines-turnover-france-and-export/
LEEM. (2018). Breakdown of medicine sales in France and abroad in 2017, by segment. Statista. Statista Inc.. Accessed: June 11, 2024. https://www.statista.com/statistics/778674/medicines-turnover-france-and-export/
LEEM. "Breakdown of Medicine Sales in France and Abroad in 2017, by Segment." Statista, Statista Inc., 2 Jul 2018, https://www.statista.com/statistics/778674/medicines-turnover-france-and-export/
LEEM, Breakdown of medicine sales in France and abroad in 2017, by segment Statista, https://www.statista.com/statistics/778674/medicines-turnover-france-and-export/ (last visited June 11, 2024)
Breakdown of medicine sales in France and abroad in 2017, by segment [Graph], LEEM, July 2, 2018. [Online]. Available: https://www.statista.com/statistics/778674/medicines-turnover-france-and-export/